IRIS UniCatt

Pinto, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.909
NA - Nord America 8.204
AS - Asia 4.246
SA - Sud America 813
Continente sconosciuto - Info sul continente non disponibili 279
AF - Africa 155
OC - Oceania 21
AN - Antartide 1
Totale 34.628
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.722
US - Stati Uniti d'America 7.906
DE - Germania 1.925
SG - Singapore 1.914
CN - Cina 930
NL - Olanda 897
SE - Svezia 803
BR - Brasile 625
FR - Francia 609
UA - Ucraina 474
GB - Regno Unito 355
VN - Vietnam 351
PL - Polonia 301
IN - India 240
IE - Irlanda 192
CA - Canada 177
ID - Indonesia 132
BD - Bangladesh 127
FI - Finlandia 116
RU - Federazione Russa 115
JP - Giappone 105
HK - Hong Kong 99
CH - Svizzera 98
TR - Turchia 67
BE - Belgio 62
ES - Italia 57
AR - Argentina 54
MX - Messico 47
ZA - Sudafrica 36
CO - Colombia 35
IQ - Iraq 35
EC - Ecuador 29
MA - Marocco 25
CI - Costa d'Avorio 23
PK - Pakistan 23
VE - Venezuela 23
IR - Iran 22
SA - Arabia Saudita 21
AL - Albania 20
AT - Austria 20
JO - Giordania 19
AU - Australia 17
MY - Malesia 17
RO - Romania 17
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 15
KR - Corea 15
LT - Lituania 15
PH - Filippine 15
AZ - Azerbaigian 14
CL - Cile 13
HU - Ungheria 13
JM - Giamaica 13
NG - Nigeria 12
PE - Perù 12
UZ - Uzbekistan 12
CR - Costa Rica 11
EG - Egitto 11
EU - Europa 11
GR - Grecia 11
PY - Paraguay 11
TH - Thailandia 10
KE - Kenya 9
TW - Taiwan 9
BZ - Belize 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
BG - Bulgaria 7
LB - Libano 7
NP - Nepal 7
BB - Barbados 6
DK - Danimarca 6
EE - Estonia 6
PT - Portogallo 6
SN - Senegal 6
BY - Bielorussia 5
ET - Etiopia 5
IL - Israele 5
SM - San Marino 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
HR - Croazia 4
IS - Islanda 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BO - Bolivia 3
CV - Capo Verde 3
GD - Grenada 3
KG - Kirghizistan 3
KH - Cambogia 3
KN - Saint Kitts e Nevis 3
KW - Kuwait 3
Totale 34.302
Salva come PNG Salva come JPEG
Città #
Milan 1.424
Rome 1.260
Singapore 1.040
Chandler 914
Ashburn 856
San Jose 715
Naples 425
Florence 264
Turin 259
Jacksonville 254
Los Angeles 212
Bologna 211
Beijing 207
Warsaw 205
San Mateo 191
Palermo 184
Dublin 178
Ann Arbor 176
Bari 170
Wilmington 143
Catania 138
New York 136
Ho Chi Minh City 129
Genoa 125
Nanjing 125
Council Bluffs 122
Verona 115
Houston 113
Jakarta 111
Lauterbourg 110
Nürnberg 107
Dearborn 103
Woodbridge 95
Munich 90
Hong Kong 89
Hanoi 83
Chicago 82
The Dalles 82
Boston 80
Fairfield 77
Frankfurt am Main 77
Dallas 75
Nanchang 75
São Paulo 73
Bremen 70
Brescia 66
Lawrence 62
Kraków 60
Padova 60
Tokyo 59
Seattle 57
Santa Clara 56
Cagliari 55
Venice 54
Parma 53
Redwood City 53
Moscow 52
Taranto 51
Cattolica 50
Hefei 50
Brussels 47
Reggio Emilia 46
Buffalo 43
Ottawa 43
Pescara 43
Princeton 43
Perugia 42
Bergamo 41
Atlanta 40
Paris 40
Messina 39
Toronto 39
Marseille 38
Salerno 37
Brooklyn 36
Lancaster 36
Livorno 35
Amsterdam 34
Modena 34
Helsinki 32
Mountain View 32
Montreal 31
Izmir 30
Redmond 30
Falls Church 29
Lucca 29
Kadoma 28
Trieste 28
Augusta 27
Kunming 27
London 27
Monza 26
Novara 26
Phoenix 26
Cambridge 25
Orem 25
Rimini 25
Tianjin 24
Abidjan 23
San Francisco 22
Totale 13.936
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.369
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.264
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 1.014
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 954
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 626
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 452
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 446
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 432
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 366
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 337
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 331
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 329
Pros-IT CNR: an Italian prostate cancer monitoring project 291
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 285
Metabolic reprogramming by malat1 depletion in prostate cancer 279
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 269
Le infezioni delle vie urinarie 264
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 256
URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY 224
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 223
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 212
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 209
The occult urothelial cancer 205
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 200
A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience 198
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 197
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 196
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 196
Bromodomain and Extra-Terminal Family Proteins BRD2, BRD3, and BRD4 Contribute to H19-Dependent Transcriptional Regulation of Cell Adhesion Molecules, Modulating Metastatic Dissemination Program in Prostate Cancer 187
Male infertility: non-surgical therapy 186
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 184
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 183
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 182
Human factors in surgery: from Three Mile Island to the operating room 181
Size of Bladder Cancers: Correlation among Different Types of Measurement 178
Therapeutic strategies in penile cancer: state of the art 178
[Overactive bladder syndrome: the social and economic perspective] 177
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 177
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 177
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 177
Imaging in prostate cancer diagnosis: present role and future perspectives 176
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 176
Hot topics in urological health economics. A mini review 176
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 174
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 172
Bladder and prostate metastasis from small cell lung cancer: a rare entity 172
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 172
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 172
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 171
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 168
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 168
Brachytherapy in men with prostate cancer: update on indications and outcomes 167
Advanced bladder cancer: New agents and new approaches. A review 166
Imaging of renal cell carcinoma: state of the art and recent advances 164
Imaging in prostate cancer staging: present role e future perspectives 163
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 161
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 161
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 159
Advanced bladder cancer: New agents and new approaches. A review 156
Circumcision: history, religion and law 152
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 152
Local relapse of prostate cancer after primary definitive treatment: the management 152
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 152
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 151
Imaging in prostate cancer staging: present role and future perspectives 151
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 151
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 150
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 150
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 147
Inhibition of prostate efferent neurotransmission by amikacin 146
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 143
The occult urothelial cancer 140
Imaging of renal cell carcinoma: state of the art and recent advances 135
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 134
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 132
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 130
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 130
Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer 130
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 128
Imaging in prostate cancer diagnosis: present role and future perspectives 128
[Doping and urologic tumors] 128
Clinical Significance of Perinephric Fluid Collection in Patients with Renal Colic and Urolithiasis: A Retrospective Analysis 125
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 123
Sports and Genitourinary Traumas 121
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 118
Anti-anginal drugs: Systematic review and clinical implications 116
Imaging of renal cell carcinoma: state of the art and recent advances. 115
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 115
Anti-Anginal drugs-beliefs and evidence: Systematic review covering 50 years of medical treatment 112
[Prostatitis syndromes and sporting activities] 112
A circulating miRNA assay as a first-line test for prostate cancer screening 111
[Sport, infertility and erectile dysfunction] 111
A circulating miRNA assay as a first-line test for prostate cancer screening 110
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 108
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 107
Circumcision: history, religion and law 106
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives 105
The cost of treatment and follow-up of bladder cancer in Italy 105
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 104
[Continuing evolution of statistical tests in medical research] 97
Totale 33.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.149 0 0 0 119 111 77 66 181 102 102 177 214
2022/20233.938 364 344 266 461 187 407 173 316 428 255 417 320
2023/20245.910 321 534 389 462 453 452 481 587 430 582 561 658
2024/20257.927 596 683 721 649 777 592 632 638 841 577 666 555
2025/20267.269 1.029 354 471 657 1.054 432 1.253 434 491 487 373 234
2026/20272.399 392 853 635 519 0 0 0 0 0 0 0 0
Totale 34.628